601089 福元医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)10.38313.93614.71620.01428.372
总资产报酬率 ROA (%)7.81210.43711.02113.55616.310
投入资产回报率 ROIC (%)10.05813.34813.87018.26324.766

边际利润分析
销售毛利率 (%)65.95567.08966.63568.23469.507
营业利润率 (%)16.76815.74516.52914.70912.701
息税前利润/营业总收入 (%)16.40114.65314.92514.12013.028
净利润/营业总收入 (%)14.98814.28114.74213.56811.133

收益指标分析
经营活动净收益/利润总额(%)95.76693.23397.22397.09997.920
价值变动净收益/利润总额(%)3.7241.9940.3320.5730.584
营业外收支净额/利润总额(%)-1.145-0.447-0.5211.9221.443

偿债能力分析
流动比率 (X)2.8962.6903.3343.2031.477
速动比率 (X)2.5212.3983.0262.8811.103
资产负债率 (%)22.81826.17123.55526.44743.557
带息债务/全部投入资本 (%)0.9111.5383.3354.4179.482
股东权益/带息债务 (%)10,662.9266,276.9052,848.4782,115.690906.669
股东权益/负债合计 (%)336.966281.191323.772277.724129.177
利息保障倍数 (X)-92.919-14.335-9.830-16.09492.512

营运能力分析
应收账款周转天数 (天)38.57036.60940.02540.80145.223
存货周转天数 (天)114.991103.965104.438115.964125.010